Indian secondaries: getting across the line

A handful of successful GP-led processes, involving household names such as CDC and Coller Capital, represent a significant step forward for the Indian secondaries market in 2018.

To view this content you must sign in:

Not yet registered? Join today to access Secondaries Investor's industry insights and updates.